Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Depth of Botulinum Neurotoxin Injection for Treatment of Glabellar Lines

NCT05766683 is registered in ClinicalTrials.gov with Henry Ford Health System as lead sponsor.

NCT NCT05766683
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05766683 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Depth of Botulinum Neurotoxin Injection for Treatment of Glabellar Lines
Lead sponsor
Henry Ford Health System
Phase
Phase 1
Overall status
Active, not recruiting
Start date
March 14, 2023
Completion date
December 31, 2026
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glabellar frown lines